Drug Delivery

The year 2007 witnessed the approval of fifteen biopharmaceuticals in the United States and European Union.

Set limits to provide incentives for process improvements.

Resolve confusion about measurements.

US Food and Drug Administration's Division of Biologic Oncology Products has approved two new biologics license application (BLA) supplements expanding the approval of Genentech's Herceptin (trastuzumab) for the treatment of breast cancer.

Nothing beats a good dictionary. It can clarify doubts, settle an argument, or prompt exploration into new areas of learning.

The transdermal delivery of biologics-as well as of conventional drugs-is growing in popularity because the technique offers numerous advantages.